Podcast Index
Parcourez les podcasts par catégorie, ouvrez les épisodes récents et téléchargez l’audio pour l’écouter hors ligne.
The Bio Report
Levine Media Group
Morning Brew Daily
Morning Brew
CBN Dinheiro - Marcelo d'Agosto
CBN
Flash Stock Reports (Video)
Flash by StockSentinel.AI
The Federal Drive with Terry Gerton
Federal News Network | Hubbard Radio
Moose on The Loose
Dividend Guy
Maritime Morning Brief
Marine Exchange of Puget Sound
Payments Brief: FinTech, Banking & Payments News
Payments Brief Team
Theo - t3․gg
Theo - t3․gg
2Bobs—with David C. Baker and Blair Enns
David C. Baker and Blair Enns
Alfa Tu Camino (Ingeniería cuántica de seducción)
Hugo Cervantes
Green Ticker Tales
Greentickertales
james h Glover Network
RevJhg3
MSTR Today: Daily insights of Michael Saylor, Bitcoin and Strategy (MicroStrategy)
John Lee Dumas
Inversión Racional Podcast
Inversión Racional
Power Talk
Berkeley Electric Cooperative
Workday Playdate
Erin Diehl - Workday Playdate
House of Arete
Kathryn Morrison
Marketplace Morning Report
Marketplace
Wish I'd Known Then Podcast For Writers
Sara Rosett and Jami Albright
Today With Jared James
Jared James
The Daily Mastery Podcast by Robin Sharma
Robin Sharma
Awkward Silences
User Interviews
HRchat Podcast
The HR Gazette
Voices of Search // A Search Engine Optimization (SEO) & Content Marketing Podcast
I Hear Everything
Financial Survival Network
Kerry Lutz
TCN Talks
Chris Comeaux
The Workplace Podcast in association with Dynamic Partners
William Corless
Handyman Success Podcast
Jason Call & Allen Lee
xHUB.AI
Plácido Doménech Espí
Small Business Pivots
Michael D. Morrison
WTR Small-Cap Spotlight
Water Tower Research
Conversations with MarTech
MarTech.org
The Think Factory Podcast
The Think Factory
Beyond Your Number
Faith and Community
Making Science
Making Science
The Live Greater View
VLP Financial Advisors
Business
Levine Media Group
Acute ischemic stroke is both ubiquitous and undertreated. Only a small fraction of patients currently receive clot-busting drugs or mechanical thrombectomy because of the small treatment window. That’s because existing ...
Plasma gelsolin is an abundant, endogenous regulator of inflammation that is consumed during severe inflammatory insults. When levels fall too low, patients are at higher risk of organ damage and death, particularly in s...
A chronic shortage of high‑quality targets remains one of the biggest constraints in drug discovery, even as therapeutic tools become more powerful and diverse. Regeneron is tackling that problem with its Regeneron Genet...
Epigenetics, the layer of chemical switches that controls how genes are turned on and off, can act like cancer’s operating system when a single epigenetic enzyme becomes essential for a tumor to survive. K36 Therapeutics...
Most marketed antibodies work as antagonists, simply shutting off a receptor, even though many immune, metabolic, and cancer pathways require more nuanced control. Metaphore Biotechnologies' function‑first platform combi...
Cells continuously sense their environment and in response to stressors, adapt, recover, or die. Soley Therapeutics uses its AI platform to capture thousands of intracellular features and map how cells sense, interpret, ...
Promising drugs can become abandoned or underused because of tolerability issues, poor drug‑like properties, or other fixable limitations, even when there is already compelling human evidence that they work. PureTech Hea...
Most cancer therapies hit one or a few pathways that tumors can escape by mutating, activating alternative survival routes, or pumping drugs out, leading to relapse and poor survival in indications such as liver, ovarian...
Gout may be one of the oldest known forms of arthritis, but it remains widely misunderstood, undertreated, and a source of silent suffering for millions of people who are often blamed for their disease rather than offere...
Small molecule drugs and monoclonal antibodies often fall short at addressing severe inflammatory and immune‑mediated diseases. Mesoblast has spent more than 15 years industrializing mesenchymal stromal cell therapies to...
Most existing therapies for multiple sclerosis do a good job of reducing relapses and inflammatory activity, but they largely fail to stop the slow neurodegeneration that drives long-term disability, especially in progre...
The treatment of inflammatory bowel disease currently relies on immunosuppressive therapies that often lose effectiveness, carry infection risks, and drive high treatment cycling. Abivax is betting that fine-tuning, rath...
Many people with the genetic condition Lynch syndrome live with the near‑certainty that they will one day develop cancer and have few options beyond constant screening and, in some cases, preventive surgery. Nouscom is t...
Alzheimer’s disease drug development has long focused on slowing memory loss, but for many families, the tipping point that makes home care impossible is not cognition—it is psychosis. Hallucinations and delusions in Alz...
RICO, the Racketeer Influenced and Corrupt Organizations Act, was originally designed to prosecute organized crime. Today, it sits at the center of a landmark class action against two of the world’s largest pharmaceutica...
Pancreatic cancer remains one of oncology’s deadliest diagnoses, with standard treatments often offering only transient tumor shrinkage at the cost of grueling side effects and rapid resistance. Immuneering is using tran...
Human leukocyte antigen, or HLA, genes, help the immune system tell the difference between the body’s own tissues and outside threats. In some people, certain versions of HLA genes mistakenly flag normal proteins as dang...
Asia is quickly becoming a powerhouse for biopharma innovation, changing ideas about where breakthrough science and fast, cost-efficient drug development happen. A new McKinsey & Company report shows how countries like C...
Leukemia once threatened Aaron Viny’s life, but now it defines his mission. Diagnosed with acute lymphoblastic leukemia as a college student, he survived chemotherapy, central nervous system relapse, and an allogeneic st...
When Amy Burroughs stepped in as CEO of Terns Pharmaceuticals, she not only had to fill a void created by the death of her predecessor, but also lead a strategic shift from an increasingly crowded area of metabolic disea...
Remplissez le formulaire ci-dessous. Veillez à sélectionner à la fois Pays et Genres.
Envoyez-nous un message ci-dessous. Nous vous répondrons dans les 24 heures.